IXIARO®- Japanese Encephalitis vaccine
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
80
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Japanese Encephalitis Vaccine
Conditions
Japanese Encephalitis Vaccine
Trial Timeline
Mar 1, 2019 → Mar 1, 2021
NCT ID
NCT03971058About IXIARO®- Japanese Encephalitis vaccine
IXIARO®- Japanese Encephalitis vaccine is a approved stage product being developed by Valneva SE for Japanese Encephalitis Vaccine. The current trial status is unknown. This product is registered under clinical trial identifier NCT03971058. Target conditions include Japanese Encephalitis Vaccine.
Hype Score Breakdown
Clinical
30
Activity
20
Company
5
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03971058 | Approved | UNKNOWN |
Competing Products
20 competing products in Japanese Encephalitis Vaccine